Medlab Clinical Ltd
ASX:MDC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Medlab Clinical Ltd
ASX:MDC
|
AU |
|
Chubb Ltd
NYSE:CB
|
CH |
|
Chemomab Therapeutics Ltd
NASDAQ:CMMB
|
IL |
|
Odyssey Gold Ltd
ASX:ODY
|
AU |
|
F
|
Fairchild Gold Corp
XTSX:FAIR
|
CA |
|
C
|
Canoo Inc
F:9XK
|
US |
|
Pierre et Vacances SA
PAR:VAC
|
FR |
|
T
|
Teads BV
NASDAQ:TEAD
|
NL |
|
A
|
Ansell Ltd
OTC:ANSLF
|
AU |
|
Cebu Air Inc
OTC:CEBUF
|
PH |
|
Amphastar Pharmaceuticals Inc
NASDAQ:AMPH
|
US |
|
E
|
EnviroGold Global Ltd
CNSX:NVRO
|
CA |
|
C
|
Compass Minerals International Inc
SWB:CM8
|
US |
|
Next Geosolutions Europe SpA
MIL:NXT
|
IT |
|
Pluri Inc
NASDAQ:PLUR
|
IL |
|
Duketon Mining Ltd
ASX:DKM
|
AU |
|
G
|
Greif Inc
F:GR3
|
US |
|
BlueScope Steel Ltd
ASX:BSL
|
AU |
|
Publicis Groupe SA
PAR:PUB
|
FR |
|
LVMH Moet Hennessy Louis Vuitton SE
OTC:LVMUY
|
FR |
Bankruptcy Probability
Medlab Clinical Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Medlab Clinical Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AU |
|
Medlab Clinical Ltd
ASX:MDC
|
15.1m AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
459.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
240.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
187.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
141.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
87.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
55.9B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
83.6B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Medlab Clinical Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Medlab Clinical Ltd has no debt.
You can find a full breakdown on its Balance Sheet.
